ENTA

Enanta Pharmaceuticals Inc

• Reuters·22h ago

  Enanta to present Phase 2b zelicapavir RSV trial data at ESCMID Global 2026

• Benzinga·03/30 11:12

  Enanta Pharma To Present Data For STAT6 Inhibitor Program At IMMUNOLOGY2026TM, Annual Meeting Of AAI

• Reuters·03/30 11:01

  Enanta to present preclinical data on oral STAT6 inhibitor EPS-3903 at IMMUNOLOGY2026

• TipRanks·03/26 12:45

  Enanta Advances Federal Circuit Appeal in Paxlovid Patent Case

• Benzinga·03/26 12:05

  12 Health Care Stocks Moving In Thursday's Pre-Market Session

• Reuters·03/26 12:02

  Enanta Pharmaceuticals appeal oral argument set for May 11, 2026; litigation targets Pfizer over Paxlovid patent infringement

• TipRanks·03/26 11:46

  Enanta initiated with a Buy at Rodman & Renshaw

• TipRanks·03/19 16:31

  Enanta’s New RSV Trial in Infants: What Investors Should Watch in ENTA

• TipRanks·03/12 20:42

  Enanta Shareholders Approve Board Elections and Equity Plan

• Reuters·03/12 20:16

  Enanta Pharmaceuticals Inc. Held Annual Shareholder Meeting

• Reuters·03/03 12:00

  Enanta Pharmaceuticals to Present at The Citizens Life Sciences Conference

• TipRanks·02/23 12:30

  Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Pelthos Therapeutics (PTHS) and Savara (SVRA)

• TipRanks·02/20 17:55

  Enanta Pharmaceuticals: RSV Monoclonal Headwinds Turn Tailwind for Zelicapavir Treatment Opportunity

• Simply Wall St·02/12 10:52

  Analysts Are Updating Their Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Estimates After Its First-Quarter Results

• TipRanks·02/11 21:51

  Enanta files $150M mixed securities shelf